Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies
Last updated: January 14, 2026 06:19 AM
Recent clinical successes, and profits, have prompted a rush among pharma companies to try new isotopes and targeting strategies